SMARCA1 and cancer: Importantly, cancer cells containing the aberrant mSWI/SNF complexes with the mutation of a particular subunit are usually vulnerable to the loss of its remaining paralogue in the residual SWI/SNF complexes, generating the synthetic lethality of cancer cells [140,141,142,143,144].